questionsmedicales.fr
Thérapeutique
Hyperthermie provoquée
Hyperthermie provoquée : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hyperthermie provoquée : Questions médicales les plus fréquentes",
"headline": "Hyperthermie provoquée : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hyperthermie provoquée : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-20",
"dateModified": "2025-03-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hyperthermie provoquée"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Thérapeutique",
"url": "https://questionsmedicales.fr/mesh/D013812",
"about": {
"@type": "MedicalCondition",
"name": "Thérapeutique",
"code": {
"@type": "MedicalCode",
"code": "D013812",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Psammothérapie",
"alternateName": "Ammotherapy",
"url": "https://questionsmedicales.fr/mesh/D000646",
"about": {
"@type": "MedicalCondition",
"name": "Psammothérapie",
"code": {
"@type": "MedicalCode",
"code": "D000646",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.565.020"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Diathermie",
"alternateName": "Diathermy",
"url": "https://questionsmedicales.fr/mesh/D003972",
"about": {
"@type": "MedicalCondition",
"name": "Diathermie",
"code": {
"@type": "MedicalCode",
"code": "D003972",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.565.280"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ultrasonothérapie",
"alternateName": "Ultrasonic Therapy",
"url": "https://questionsmedicales.fr/mesh/D014464",
"about": {
"@type": "MedicalCondition",
"name": "Ultrasonothérapie",
"code": {
"@type": "MedicalCode",
"code": "D014464",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.565.280.945"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Chimiothérapie hyperthermique intrapéritonéale",
"alternateName": "Hyperthermic Intraperitoneal Chemotherapy",
"url": "https://questionsmedicales.fr/mesh/D000084262",
"about": {
"@type": "MedicalCondition",
"name": "Chimiothérapie hyperthermique intrapéritonéale",
"code": {
"@type": "MedicalCode",
"code": "D000084262",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.565.370"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Bain de vapeur",
"alternateName": "Steam Bath",
"url": "https://questionsmedicales.fr/mesh/D029002",
"about": {
"@type": "MedicalCondition",
"name": "Bain de vapeur",
"code": {
"@type": "MedicalCode",
"code": "D029002",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.565.640"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hyperthermie provoquée",
"alternateName": "Hyperthermia, Induced",
"code": {
"@type": "MedicalCode",
"code": "D006979",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Mohammad-Amin Abdollahifar",
"url": "https://questionsmedicales.fr/author/Mohammad-Amin%20Abdollahifar",
"affiliation": {
"@type": "Organization",
"name": "Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: abdollahima@sbmu.ac.ir."
}
},
{
"@type": "Person",
"name": "Abbas Aliaghaei",
"url": "https://questionsmedicales.fr/author/Abbas%20Aliaghaei",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran."
}
},
{
"@type": "Person",
"name": "Jon E Sprague",
"url": "https://questionsmedicales.fr/author/Jon%20E%20Sprague",
"affiliation": {
"@type": "Organization",
"name": "The Ohio Attorney General's Center for the Future of Forensic Science, USA. Electronic address: jesprag@bgsu.edu."
}
},
{
"@type": "Person",
"name": "Amir Raoofi",
"url": "https://questionsmedicales.fr/author/Amir%20Raoofi",
"affiliation": {
"@type": "Organization",
"name": "Leishmaniasis Research Center, Department of Anatomy, Sabzevar University of Medical Sciences, Sabzevar, Iran."
}
},
{
"@type": "Person",
"name": "Shabnam Abdi",
"url": "https://questionsmedicales.fr/author/Shabnam%20Abdi",
"affiliation": {
"@type": "Organization",
"name": "Department of Anatomical Sciences & Cognitive Neuroscience, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Clinical Pharmacology of RNA Interference-Based Therapeutics: A Summary Based on Food and Drug Administration-Approved Small Interfering RNAs.",
"datePublished": "2022-11-04",
"url": "https://questionsmedicales.fr/article/36332914",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1124/dmd.122.001107"
}
},
{
"@type": "ScholarlyArticle",
"name": "Carbon Dots with Guanidinium and Amino Acid Functional Groups for Targeted Small Interfering RNA Delivery toward Tumor Gene Therapy.",
"datePublished": "2023-02-25",
"url": "https://questionsmedicales.fr/article/36840641",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/smll.202207204"
}
},
{
"@type": "ScholarlyArticle",
"name": "Short interfering RNA in colorectal cancer: is it wise to shoot the messenger?",
"datePublished": "2023-04-01",
"url": "https://questionsmedicales.fr/article/37011722",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejphar.2023.175699"
}
},
{
"@type": "ScholarlyArticle",
"name": "Combination treatments including the small-interfering RNA JNJ-3989 induce rapid and sometimes prolonged viral responses in patients with CHB.",
"datePublished": "2022-07-20",
"url": "https://questionsmedicales.fr/article/35870702",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jhep.2022.07.010"
}
},
{
"@type": "ScholarlyArticle",
"name": "Tetrahedral Framework Nucleic Acids Based Small Interfering RNA Targeting Receptor for Advanced Glycation End Products for Diabetic Complications Treatment.",
"datePublished": "2023-09-26",
"url": "https://questionsmedicales.fr/article/37751401",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acsnano.3c06999"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Thérapeutique",
"item": "https://questionsmedicales.fr/mesh/D013812"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hyperthermie provoquée",
"item": "https://questionsmedicales.fr/mesh/D006979"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hyperthermie provoquée - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hyperthermie provoquée",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hyperthermie provoquée",
"description": "Comment diagnostiquer l'hyperthermie provoquée ?\nQuels tests sont utilisés pour confirmer l'hyperthermie ?\nQuels signes cliniques indiquent une hyperthermie ?\nL'hyperthermie est-elle toujours dangereuse ?\nComment différencier l'hyperthermie de la fièvre ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=RNA,+Small+Interfering&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hyperthermie provoquée",
"description": "Quels sont les symptômes de l'hyperthermie provoquée ?\nL'hyperthermie provoquée cause-t-elle des douleurs ?\nPeut-on avoir des troubles de la conscience ?\nY a-t-il des signes cutanés associés ?\nL'hyperthermie provoquée affecte-t-elle la respiration ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=RNA,+Small+Interfering&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hyperthermie provoquée",
"description": "Comment prévenir l'hyperthermie provoquée ?\nLes vêtements influencent-ils l'hyperthermie ?\nFaut-il surveiller la température corporelle ?\nLes pauses sont-elles importantes ?\nL'alimentation joue-t-elle un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=RNA,+Small+Interfering&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hyperthermie provoquée",
"description": "Comment traiter l'hyperthermie provoquée ?\nDes médicaments sont-ils nécessaires ?\nQuelle est l'importance de l'hydratation ?\nQuand faut-il consulter un médecin ?\nLe repos est-il recommandé ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=RNA,+Small+Interfering&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hyperthermie provoquée",
"description": "Quelles complications peuvent survenir ?\nL'hyperthermie peut-elle être mortelle ?\nQuels organes sont les plus affectés ?\nDes séquelles peuvent-elles persister ?\nComment éviter les complications graves ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=RNA,+Small+Interfering&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hyperthermie provoquée",
"description": "Qui est le plus à risque d'hyperthermie ?\nL'exercice augmente-t-il le risque ?\nLes médicaments influencent-ils le risque ?\nL'humidité joue-t-elle un rôle ?\nLe surpoids est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=RNA,+Small+Interfering&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hyperthermie provoquée ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation clinique et la mesure de la température corporelle."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer l'hyperthermie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des évaluations physiologiques peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une hyperthermie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une température élevée, des frissons et une confusion mentale."
}
},
{
"@type": "Question",
"name": "L'hyperthermie est-elle toujours dangereuse ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, elle peut être contrôlée, mais nécessite une surveillance."
}
},
{
"@type": "Question",
"name": "Comment différencier l'hyperthermie de la fièvre ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hyperthermie est causée par des facteurs externes, alors que la fièvre est une réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'hyperthermie provoquée ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vertiges, des maux de tête et une confusion."
}
},
{
"@type": "Question",
"name": "L'hyperthermie provoquée cause-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des douleurs musculaires et des crampes."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des troubles de la conscience ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la conscience peuvent survenir en cas d'hyperthermie sévère."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cutanés associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des rougeurs ou des éruptions cutanées peuvent apparaître en cas d'hyperthermie."
}
},
{
"@type": "Question",
"name": "L'hyperthermie provoquée affecte-t-elle la respiration ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner une respiration rapide et superficielle."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hyperthermie provoquée ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les environnements chauds et hydratez-vous régulièrement lors d'activités physiques."
}
},
{
"@type": "Question",
"name": "Les vêtements influencent-ils l'hyperthermie ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, porter des vêtements légers et respirants aide à prévenir l'hyperthermie."
}
},
{
"@type": "Question",
"name": "Faut-il surveiller la température corporelle ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, surveiller la température est essentiel lors d'activités à risque."
}
},
{
"@type": "Question",
"name": "Les pauses sont-elles importantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, prendre des pauses régulières lors d'activités physiques intenses est crucial."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée aide à maintenir une bonne régulation thermique."
}
},
{
"@type": "Question",
"name": "Comment traiter l'hyperthermie provoquée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut le refroidissement du corps et l'hydratation adéquate."
}
},
{
"@type": "Question",
"name": "Des médicaments sont-ils nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être administrés pour soulager les symptômes associés."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'hydratation ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hydratation est cruciale pour prévenir des complications graves liées à l'hyperthermie."
}
},
{
"@type": "Question",
"name": "Quand faut-il consulter un médecin ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin si les symptômes persistent ou s'aggravent malgré le traitement."
}
},
{
"@type": "Question",
"name": "Le repos est-il recommandé ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le repos est essentiel pour permettre au corps de récupérer."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des coups de chaleur, des défaillances organiques et des convulsions."
}
},
{
"@type": "Question",
"name": "L'hyperthermie peut-elle être mortelle ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une hyperthermie sévère non traitée peut entraîner la mort."
}
},
{
"@type": "Question",
"name": "Quels organes sont les plus affectés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le cerveau, le cœur et les reins sont particulièrement vulnérables à l'hyperthermie."
}
},
{
"@type": "Question",
"name": "Des séquelles peuvent-elles persister ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des séquelles neurologiques peuvent persister après une hyperthermie sévère."
}
},
{
"@type": "Question",
"name": "Comment éviter les complications graves ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement rapide et approprié est essentiel pour éviter les complications graves."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'hyperthermie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées, les enfants et celles avec des maladies chroniques sont plus à risque."
}
},
{
"@type": "Question",
"name": "L'exercice augmente-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice intense dans des environnements chauds augmente le risque d'hyperthermie."
}
},
{
"@type": "Question",
"name": "Les médicaments influencent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent altérer la régulation thermique et augmenter le risque."
}
},
{
"@type": "Question",
"name": "L'humidité joue-t-elle un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une humidité élevée augmente le risque d'hyperthermie en réduisant l'évaporation de la sueur."
}
},
{
"@type": "Question",
"name": "Le surpoids est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le surpoids peut augmenter le risque d'hyperthermie en réduisant l'efficacité de la thermorégulation."
}
}
]
}
]
}
RNA-based oligonucleotide therapeutics are revolutionizing drug development for disease treatment. This class of therapeutics differs from small molecules and protein therapeutics in various ways, inc...
Small interfering RNA (siRNA)-based gene therapy represents a promising strategy for tumor treatment. Novel gene vectors that can achieve targeted delivery of siRNA to the tumor cells without causing ...
Colorectal cancer (CRC) is the third most common cancer and the leading cause of gastrointestinal cancer death. 90% of people diagnosed with colorectal cancer are over the age of 50; nevertheless, the...
RNA interference therapy has been shown to reduce hepatitis B surface antigen (HBsAg) levels in preclinical models, which could confer functional cure in patients with chronic hepatitis B. This phase ...
Treatment-naïve and NA-suppressed patients received 3 subcutaneous JNJ-3989 doses every week (QW; 100, 200, or 300 mg), 2 weeks (Q2W; 100 mg) or 4 weeks (Q4W; 25, 50, 100, 200, 300, or 400 mg), or JNJ...
Eighty-four patients were recruited. All treatments were well tolerated, with all 5 serious adverse events considered unrelated to study drugs. JNJ-3989 100 to 400 mg Q4W resulted in HBsAg reductions ...
JNJ-3989 plus an NA, with/without JNJ-6379, was well tolerated and resulted in HBsAg reductions up to 336 days after the last JNJ-3989 Q4W dose....
NCT03365947....
Hepatitis B virus affects people's livers and produces particles called hepatitis B surface antigen (HBsAg) that damage a person's liver and can help the virus infect a person for a long time, known a...
Complications arising from diabetes can threaten multiple organs. Advanced glycation end products (AGEs) play a significant role in inducing these complications. Highly processed diets and hyperglycem...
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of mortality worldwide. Atherosclerosis occurs due to accumulation of low-density lipoprotein cholesterol (LDL-c) in the arterial sy...
The purpose of this study is to examine the effects of PCSK9 inhibitors and small interfering RNA (siRNA) therapy on LDL-c reduction and major adverse cardiac events (MACE) and mortality by conducting...
Using Pubmed, Embase, Cochrane Library and clinicaltrials.gov until April 2023, we extracted randomized controlled trials (RCTs) of PCSK9 inhibitors (Evolocumab, Alirocumab) and siRNA therapy (Inclisi...
In all, 54 studies with 87,669 participants (142,262 person-years) met criteria for inclusion. LDL-c percent change was reported in 47 studies (n = 62,634) evaluating two PCSK9 inhibitors and siRNA th...
PCSK9 inhibitors (Evolocumab, Alirocumab) and siRNA therapy (Inclisiran) significantly reduced LDL-c by >40% in high-risk individuals. Additionally, both Alirocumab and Evolocumab reduced the risk of ...
The PCSK9 (Proprotein Convertase Subtilisin/Kexin type 9) enzyme interferes with the metabolism of low-density lipoprotein (LDL) cholesterol. Inhibition of PCSK9 results in lower LDL cholesterol level...
There is overwhelming clinical and genetic evidence supporting the concept that low-density-lipoprotein cholesterol should be as low as possible for as long as possible in patients at very high cardio...
To date, no medical therapy can slow the progression of aortic stenosis. Fibrocalcific stenosis is the most frequent form in the general population and affects about 6% of the elderly population. Over...
MicroRNAs (miRNAs) and small interfering RNAs (siRNAs) are loaded into Argonaute (AGO) proteins, forming RNA-induced silencing complexes (RISCs). The assembly process establishes the seed, central, 3'...